Potential role of tigecycline in the treatment of community-acquired bacterial pneumonia

Tigecycline is a member of the glycylcycline class of antimicrobials, which is structurally similar to the tetracycline class. It demonstrates potent in vitro activity against causative pathogens that are most frequently isolated in patients with community-acquired bacterial pneumonia (CABP), includ...

Descripción completa

Detalles Bibliográficos
Autores principales: Townsend, Mary L, Pound, Melanie W, Drew, Richard H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108749/
https://www.ncbi.nlm.nih.gov/pubmed/21694911
http://dx.doi.org/10.2147/IDR.S6030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108749/
https://www.ncbi.nlm.nih.gov/pubmed/21694911
http://dx.doi.org/10.2147/IDR.S6030

Ejemplares similares